Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Regeneus Ltd

INVESTOR PRESENTATION - Regeneus Ltd

ASX:RGS

Regeneus Ltd

Health

Regeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.

Read more

Market Cap

$36.03m

Price at Close

$0.12

4w avg. Volume

160.59k

4w avg. Turnover

$19.29k

Announcements
announcementt+2 movementdate
  • Lapse of Unlisted Share Options

    Issued Capital

  • +9.09%

    19 Nov 2020

+9.09%

19 Nov 2020
  • Appendix 3Y - Leo Lee

    Shareholder Details

  • +9.09%

    19 Nov 2020

+9.09%

19 Nov 2020
  • Appendix 3Y - Alan Dunton

    Shareholder Details

  • +9.09%

    19 Nov 2020

+9.09%

19 Nov 2020
  • Appendix 3Y - John Chiplin

    Shareholder Details

  • +9.09%

    19 Nov 2020

+9.09%

19 Nov 2020
  • Appendix 3Y - Graham Vesey

    Shareholder Details

  • +9.09%

    19 Nov 2020

+9.09%

19 Nov 2020
  • Clarification on Quarterly Activity Report and Appendix 4C

    Commitments test entity quarterly reports · Market sensitive

  • -4.17%

    10 Nov 2020

-4.17%

10 Nov 2020
  • Material Terms of Contract for Chief Executive Officer

    Company Administration

  • -8.00%

    02 Nov 2020

-8.00%

02 Nov 2020
  • CEO Appointment and Resignation

    Company Administration · Market sensitive

  • -8.00%

    01 Nov 2020

-8.00%

01 Nov 2020
  • Annual Report Additional Information

    Periodic Reports

  • -11.11%

    30 Oct 2020

-11.11%

30 Oct 2020
  • Appendix 4C - Quarterly

    Commitments test entity quarterly reports · Market sensitive

  • -11.11%

    30 Oct 2020

-11.11%

30 Oct 2020
Market Data

Current Price

$0.12

52WK HIGH

$0.2

52WK LOW

$0.049

1YR RETURN

+64.47%

1YR RETURN VS. SECTOR

+26.96%

90 DAY RETURN

-10.71%

ASX RANK

1,285

/2,047

SECTOR RANK

121

/168

SHARES OUTSTANDING

300.28m
ASX:RGS

Regeneus Ltd

Health

Regeneus Limited (RGS) is a Sydney based regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases.

Read more

Market Cap

$36.03m

Price at Close

$0.12

4w avg. Volume

160.59k

4w avg. Turnover

$19.29k

ASX:RGS is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.